
Journal of labelled compounds and radiopharmaceuticals p. 363 - 376 (1998)
Update date:2022-08-03
Topics:
Waterhouse, Rikki N.
Gotsick, J. Timothy
Kabalka, George W.
Goodman, Mark M.
O'Brien
[123I]-8-[4-[2-(5-Iodothienyl)]-4-oxobutyl]-3-methyl-1-phenyl-1,3,8- triazaspiro[4.5]-decan-4-one (1) has been synthesized as a potential ligand for dopamine D2 receptors. This new compound proved to be moderate in lipophilicity (log
View MoreDaicel Chiral Technologies (China)CO.,LTD
Contact:021-5046-0086*8
Address:Part C, FL 5, the 16th Building, No. 69, XiYa Road, WaiGaoQiao Free Trade Zone, Shanghai, 200131, P.R.China
Jiangsu Chiatai Qingjiang Pharmaceutical Co.,Ltd
Contact:+86-517-86283327
Address:9 North Hantai Road, Huaian, China
Zhejiang Kente Chemical Co.,Ltd.
Contact:86-0576-87651912
Address:No.7, Fengxi West Road, Modern Industrial Zone
KA-SHING Business Trade Macau Co., Ltd.
Contact:00853-28430045
Address:23rd Floor, Block 3 La Cite, Areia Preta, Macao
Jiangsu Cale New Material Co.ltd
Contact:+86-515-88334667/88203550
Address:Zhongshan 3rd Road, Coastal Chemical Industry Park, Yancheng, Jiangsu, China
Doi:10.1016/S0040-4020(01)96351-3
(1968)Doi:10.1002/1521-3765(20001215)6:24<4558::AID-CHEM4558>3.0.CO;2-6
(2000)Doi:10.1002/hlca.19840670720
(1984)Doi:10.1016/S0960-894X(98)00194-2
(1998)Doi:10.1016/S0040-4020(98)00467-0
(1998)Doi:10.1055/s-1998-1819
(1998)